Back to company

BIOPTIMATE ApS: Financial statements 2018

CVR: 36051183

BIOPTIMATE ApS (CVR 36051183) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 12,582 and a net result of DKK 12,986 compared with DKK -24,306 the year before. Equity amounted to DKK 87,916. The solvency ratio was 82.7%.

Gross Profit
12,582 kr.
Profit/Loss
12,986 kr.
Equity
87,916 kr.
Total Assets
106,333 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-13 t.13 t.88 t.-
2017--20 t.-24 t.75 t.-
2016--13 t.39 t.99 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on BIOPTIMATE ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

BIOPTIMATE ApS: The 2017 annual report is outJun 21, 2018

BIOPTIMATE ApS has published its annual report for 2017. Gross profit came to DKK -19,801, and the net result was DKK -24,306.

About BIOPTIMATE ApS

BIOPTIMATE ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Christian Sørensen. The company is owned by Pure20 ApS. In 2024, the company reported a gross profit of DKK -2,075,727 and a net result of DKK -6,367,118 compared with DKK -4,997,291 the year before. Equity amounted to DKK -3,855,665.